Abstract:Purpose: To evaluate diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging (MRI) for predicting microvascular invasion (MVI) of hepatocellular carcinoma (HCC) in patients with hepatitis B virus. Materials and Methods: This study was approved by our institutional review board, and the informed consent was waived. 107 patients accepted MR scanning before operation. Subsequently, 106 patients were performed liver mass resection, and one with liver transplantation. All images were evaluated by two radiologists with at least 9 years experience in abdominal MR imaging. The imaging features of tumors were as follows: peritumoral arterial enhancement, tumor pseudo-capsule, tumor margins, as well as multifocality. MVI, tumor size, Edmondson-Steiner grade and liver cirrhosis were also included. The independent Student's t-test was used to compare continuous variables, and the chi-squared test and Fisher's Exact test was used to analyze the categorical variables. Parameters shown to be statistically significant in univariate analysis were entered into a logistic regression model to identify independent predictors of MVI. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. A p-value less than 0.05 was considered to be statistically significant. Results: By histopathologic analysis, 31.8% (34/107) of the patients with HCC were confirmed as MVI-positive, and 68.2% (73/107) were as MVI-negative. MVI was present in 11.8% (4/34) of tumors less than 5 cm with smooth margins; and 68.4% (13/19) of tumors larger than 5 cm with non-smooth margins. A larger (> 5 cm) tumor size (odds ratio [OR] 4.77, 95% CI 1.50-15.17; P < 0.05) and a non-smooth MRI tumor margin (OR 3.79, 95% CI 1.07-13.43; P < 0.05) were shown as independent predictors of MVI. The sensitivity, specificity, PPV, and NPV for predicting MVI by tumor size > 5 cm were 41.2% (95% CI 25.1-59.2), 86.3% (95% CI 75.8-92.9), 58.3% (95% CI 36.9-77.2), and 75.9% (95% CI 65.0-84.3), respectively. The sensitivity, specificity, PPV, and NPV for predicting MVI by a non-smooth margin were 87.1% (95% CI 69.2-95.8), 48.6% (95% CI 36.6-60.7), 42.9% (95% CI 30.7-55.9), and 89.5% (95% CI 74.3-96.6), respectively. When combining the tumor size (> 5 cm) with tumor margin (non-smooth margin) as the risk factors, the area under ROC curve was 0.732 (95% CI 0.624-0.840), and the OR value was 4.11 (95% CI 1.99-8.48; P < 0.05) for predicting presence of MVI. Conclusion: a non-smooth tumor margin and a larger tumor size could independently predict the presence of MVI. A tumor size > 5 cm and a non-smooth tumor margin could be used as preoperative predictors of the presence of MVI in patients with HCC.

Extracellular Contrast Agent-Enhanced MRI is As Effective As Gadoxetate Disodium-Enhanced MRI for Predicting Microvascular Invasion in HCC.

Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents

Comparison of Sonazoid-Contrast‑Enhanced Ultrasound and Gd‑EOB‑DTPA‑Enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma

The diagnostic performance of contrast-enhanced CT versus extracellular contrast agent-enhanced MRI in detecting hepatocellular carcinoma: direct comparison and a meta-analysis

Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents

Radiomics of Preoperative Multi-Sequence Magnetic Resonance Imaging Can Improve the Predictive Performance of Microvascular Invasion in Hepatocellular Carcinoma

Gd-EOB-DTPA enhanced MRI is superior in selecting surgical candidates for patients with early-stage hepatocellular carcinoma: An analysis in terms of oncological outcomes

Gd-EOB-DTPA-enhanced MRI Proves Advantageous in Selecting Surgical Candidates for Patients with Early-Stage Hepatocellular Carcinoma: an Analysis in Terms of Oncological Outcomes

Profiling Hepatocellular Carcinoma Aggressiveness with Contrast-Enhanced Ultrasound and Gadoxetate Disodium-Enhanced MRI: an Intra-Individual Comparative Study Based on the Liver Imaging Reporting and Data System.

Combined Hepatocellular-Cholangiocarcinoma: Which Preoperative Clinical Data and Conventional MRI Characteristics Have Value for the Prediction of Microvascular Invasion and Clinical Significance?

Predict Microvascular Invasion in Hepatocellular Carcinoma by Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients with Hepatitis B Virus

A Nomogram Based on Contrast-Enhanced Ultrasound to Predict the Microvascular Invasion in Hepatocellular Carcinoma.

Preoperative Prediction of Microvascular Invasion of Hepatocellular Carcinoma with IVIM Diffusion-Weighted MR Imaging and Gd-EOB-DTPA-enhanced MR Imaging.

The Value of Contrast-Enhanced Magnetic Resonance Imaging for Diagnosis of Extrahepatic Cholangiocarcinoma

Predicting Histologic Differentiation of Solitary Hepatocellular Carcinoma Up to 5 Cm on Gadoxetate Disodium-Enhanced MRI

Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data

Preoperative Evaluation of MRI Features and Inflammatory Biomarkers in Predicting Microvascular Invasion of Combined Hepatocellular Cholangiocarcinoma

Prediction of Microvascular Invasion in Hepatocellular Carcinoma: Preoperative Gd-EOB-DTPA-Dynamic Enhanced MRI and Histopathological Correlation

Using Pre-Operative Radiomics to Predict Microvascular Invasion of Hepatocellular Carcinoma Based on Gd-EOB-DTPA Enhanced MRI.

Clinical and DCE-CT signs in predicting microvascular invasion in cHCC-ICC

Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators